Tenax Therapeutics (TENX) Total Debt (2011 - 2021)
Tenax Therapeutics recorded quarterly Total Debt of $31080.0 in Q1 2021, down 74.97% quarter-over-quarter from $124166.0 in Q4 2020.
Tenax Therapeutics' Total Debt history runs 5 years deep, the most recent figure standing at $31080.0 for Q1 2021.
- In Q1 2021, Total Debt changed N/A year-over-year to $31080.0; the TTM figure through Mar 2021 stood at $31080.0 (changed N/A YoY), while the FY2020 annual figure was $124166.0, changed N/A from the prior year.
- Total Debt came in at $31080.0 for Q1 2021 at Tenax Therapeutics, down from $124166.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $213757.0 in Q3 2020 to a low of $31080.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 31,080.00 |
| Dec 31, 2020 | 124,166.00 |
| Sep 30, 2020 | 213,757.00 |
| Jun 30, 2020 | 137,051.00 |
| Apr 30, 2013 | 2.99 Mn |
| Jan 31, 2013 | 2.59 Mn |
| Oct 31, 2012 | 2.18 Mn |
| Jul 31, 2012 | 1.77 Mn |
| Apr 30, 2012 | 1.36 Mn |
| Jan 31, 2012 | 952,777.00 |
| Oct 31, 2011 | 6.18 Mn |
| Jul 31, 2011 | 5.53 Mn |
| Apr 30, 2011 | 4.46 Mn |